Online Inquiry
Cat.#: BBM-C-149
| Source | Brain |
| Disease | Normal |
| Species | Bovine |
| Cell Type | Astrocytes |
| Description | Bovine astrocytes from Ace Therapeutics are isolated from the bovine brain and are cryopreserved at passage one. Bovine astrocytes are characterized by immunofluorescence with antibody specific to GFAP. Each vial contains at least 0.5×10^6 cells per ml and is delivered frozen. |
| Applications | Bovine Astrocytes are a useful in vitro model for studying glial function and the molecular mechanisms of CNS diseases such as ischemic stroke and multiple sclerosis. |
| Quality Control | Bovine Astrocytes test negative for bacteria, yeast, fungi, and mycoplasma. |
| Shipping and Storage | Ace Therapeutics ships frozen cells using dry ice. Upon receiving the frozen cells, immediately move them into liquid nitrogen (-180 °C) for storage. Note: Never can cells be kept at -20 °C, and repeated freezing and thawing of cells is not recommended. |
| Cat.# | Name | Description | Price |
|---|---|---|---|
| BBM-C-138 | C57BL/6 Mouse Astrocytes |
C57BL/6 Mouse Astrocytes from Ace Therapeutics are isolated from brain tissues of pathogen-free laboratory mice. Each vial contains at least 1×10^6 cells per ml and is delivered frozen.
|
inquiry |
| BBM-C-142 | Mouse Astrocytes-brain stem from CD1 |
Mouse Astrocytes-brain stem from CD1 (MA-bs) are isolated from embryonic day 15 mouse brain stem. MA-bs are cryopreserved as primary cultures and delivered frozen.
|
inquiry |
| BBM-C-123 | Human Brain Microvascular Pericytes |
Human brain microvascular pericytes (HBMVPCs) perform numerous tasks which include playing a vital part in constructing and maintaining the blood-brain barrier, controlling angiogenesis, ensuring endothelial cell survival, and engulfing cellular waste.
Human Brain Microvascular Pericytes from Ace Therapeutics are isolated from normal human brain cortical tissue. Each vial contains at least 5×10^5 cells per ml and is delivered frozen.
|
inquiry |
| BBM-C-147 | Rat Astrocytes-midbrain |
Rat astrocytes-midbrain (RA-mb) from Ace Therapeutics are isolated from CD® IGS rat midbrain and are cryopreserved at P0. RA-mb are characterized by immunofluorescence with antibodies specific to GFAP. Each vial contains at least 0.5×10^6 cells per ml and is delivered frozen.
|
inquiry |
| BBM-C-130 | Bovine Brain Microvascular Endothelial Cells |
Bovine Brain Microvascular Endothelial Cells (BBMVEC) from Ace Therapeutics are isolated from microvessels of the bovine brain. The cells are cryopreserved at the second passage.
|
inquiry |
| BBM-C-126 | C57BL/6 Mouse Embryonic Brain Endothelial Cells |
C57BL/6 Mouse Embryonic Brain Endothelial Cells from Ace Therapeutics are isolated from brain tissue of pathogen-free laboratory mice at embryonic day 14.5-19. Each vial contains at least 1×10^6 cells per ml and is delivered frozen.
|
inquiry |
| BBM-C-131 | Cynomolgus Monkey Brain Microvascular Endothelial Cells |
Cynomolgus Monkey Brain Microvascular Endothelial Cells from Ace Therapeutics are isolated from Cynomolgus monkey brain tissue. Each vial contains at least 1×10^6 cells per ml and is delivered frozen.
|
inquiry |
| BBM-C-144 | Rat Astrocytes |
Rat Astrocytes (RA) from Ace Therapeutics are isolated from postnatal day 2 rat brains and are cryopreserved as primary cultures. Each vial contains at least 0.5×10^6 cells per ml and is delivered frozen.
|
inquiry |
| BBM-C-143 | Mouse Astrocytes-cerebellar from CD1 |
Mouse Astrocytes-cerebellar from CD1 from Ace Therapeutics are isolated from a pathogen-free mouse cerebellar and are cryopreserved as primary cultures. Each vial contains at least 0.5×10^6 cells per ml and is delivered frozen.
|
inquiry |
| BBM-C-133 | Canine Brain Microvascular Endothelial Cells |
Canine Brain Microvascular Endothelial Cells from Ace Therapeutics are isolated from the brain of a pathogen-free laboratory beagle dog. Each vial contains at least 0.5×10^6 cells per ml and is delivered frozen.
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.